Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of SGN-00101 In The Treatment of Pediatric Recurrent Respiratory Papillomatosis

NCT00038714 is registered in ClinicalTrials.gov with Nventa Biopharmaceuticals Corporation as lead sponsor.

NCT NCT00038714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00038714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of SGN-00101 In The Treatment of Pediatric Recurrent Respiratory Papillomatosis
Lead sponsor
Nventa Biopharmaceuticals Corporation
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2001
Completion date
January 31, 2004
Enrollment
27 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

papilloma, recurrent respiratory papillomatosis